BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 25968808)

  • 1. Serum paraoxonase and arylesterase activities in patients with chronic otitis media.
    Turan M; Ucler R; Aslan M; Kalkan F; Taskın A; Garca MF; Cankaya H
    Redox Rep; 2015; 20(6):241-5. PubMed ID: 25968808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative status and serum PON1 activity in beta-thalassemia minor.
    Selek S; Aslan M; Horoz M; Gur M; Erel O
    Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum paraoxonase activity and oxidative stress in patients with adult nephrotic syndrome.
    Soyoral YU; Aslan M; Emre H; Begenik H; Erdur FM; Turkel A; Selek S; Erkoc R
    Atherosclerosis; 2011 Sep; 218(1):243-6. PubMed ID: 21723555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia.
    Aslan M; Kosecik M; Horoz M; Selek S; Celik H; Erel O
    Atherosclerosis; 2007 Apr; 191(2):397-402. PubMed ID: 16684543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase and arylesterase activities in fibromyalgia.
    Altindag O; Gur A; Calgan N; Soran N; Celik H; Selek S
    Redox Rep; 2007; 12(3):134-8. PubMed ID: 17623520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum paraoxonase-1 activity in Helicobacter pylori infected subjects.
    Aslan M; Nazligul Y; Horoz M; Bolukbas C; Bolukbas FF; Gur M; Celik H; Erel O
    Atherosclerosis; 2008 Jan; 196(1):270-274. PubMed ID: 17125774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of serum paraoxonase and arylesterase activities in early pregnancy failure.
    Toy H; Camuzcuoglu H; Celik H; Erel O; Aksoy N
    Swiss Med Wkly; 2009 Feb; 139(5-6):76-81. PubMed ID: 19204840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased serum paraoxonase and arylesterase activities in patients with rosacea.
    Takci Z; Bilgili SG; Karadag AS; Kucukoglu ME; Selek S; Aslan M
    J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):367-370. PubMed ID: 24854673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced PON1 enzymatic activity and increased lipid hydroperoxide levels that point out oxidative stress in generalized anxiety disorder.
    Bulut M; Selek S; Bez Y; Karababa IF; Kaya MC; Gunes M; Emhan A; Aksoy N; Sir A
    J Affect Disord; 2013 Sep; 150(3):829-33. PubMed ID: 23706841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PON1 status in haemodialysis patients and the impact of hepatitis C infection.
    Horoz M; Aslan M; Selek S; Koylu AO; Bolukbas C; Bolukbas FF; Celik H; Erel O
    Clin Biochem; 2007 Jun; 40(9-10):609-14. PubMed ID: 17335792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of paraoxonase activity and atherosclerosis in patients with chronic hepatitis B.
    Karsen H; Binici I; Sunnetcioglu M; Baran AI; Ceylan MR; Selek S; Celik H
    Afr Health Sci; 2012 Jun; 12(2):114-8. PubMed ID: 23056015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acetaminophen intoxication is associated with decreased serum paraoxonase and arylesterase activities and increased lipid hydroperoxide levels.
    Karadas S; Aslan M; Gonullu H; Kati C; Duran L; Olmez S; Kucukoglu ME; Demir H
    Hum Exp Toxicol; 2014 Nov; 33(11):1134-40. PubMed ID: 24501102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of paraoxonase activities in patients with knee osteoarthritis.
    Soran N; Altindag O; Cakir H; Celik H; Demirkol A; Aksoy N
    Redox Rep; 2008; 13(5):194-8. PubMed ID: 18796237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress in chronic otitis media.
    Baysal E; Aksoy N; Kara F; Taysi S; Taşkın A; Bilinç H; Cevik C; Celenk F; Kanlıkama M
    Eur Arch Otorhinolaryngol; 2013 Mar; 270(4):1203-8. PubMed ID: 22711004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraoxonase and arylesterase activities in patients with papillary thyroid cancer.
    Korkmaz H; Tabur S; Özkaya M; Aksoy N; Yildiz H; Akarsu E
    Scand J Clin Lab Invest; 2015 May; 75(3):259-64. PubMed ID: 25723374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients.
    Yildiz A; Gur M; Demirbag R; Yilmaz R; Akyol S; Aslan M; Erel O
    Clin Biochem; 2008 Jul; 41(10-11):779-84. PubMed ID: 18355454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lipid hydroperoxide levels and paraoxonase activity in patients with lung, breast, and colorectal cancer.
    Balci H; Genc H; Papila C; Can G; Papila B; Yanardag H; Uzun H
    J Clin Lab Anal; 2012 May; 26(3):155-60. PubMed ID: 22628230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraoxonase and arylesterase activities in coronary artery disease.
    Gur M; Aslan M; Yildiz A; Demirbag R; Yilmaz R; Selek S; Erel O; Ozdogru I
    Eur J Clin Invest; 2006 Nov; 36(11):779-87. PubMed ID: 17032345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum paraoxonase and arylesterase activities in patients with epithelial ovarian cancer.
    Camuzcuoglu H; Arioz DT; Toy H; Kurt S; Celik H; Erel O
    Gynecol Oncol; 2009 Mar; 112(3):481-5. PubMed ID: 19101714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum paraoxonase enzyme activity and oxidative stress in obese subjects.
    Aslan M; Horoz M; Sabuncu T; Celik H; Selek S
    Pol Arch Med Wewn; 2011 Jun; 121(6):181-6. PubMed ID: 21694681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.